Prevalence and Prognostic Value of Unrecognized Myocardial Injury in Stable Coronary Artery Disease (PUMI)
PUMI
1 other identifier
observational
275
1 country
6
Brief Summary
This study includes patients with stable coronary artery disease without previously known myocardial infarction, and investigates the prevalence of clinically unrecognized myocardial damage and its prognostic implication.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2007
Longer than P75 for all trials
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2007
CompletedFirst Submitted
Initial submission to the registry
December 6, 2010
CompletedFirst Posted
Study publicly available on registry
December 9, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2013
CompletedDecember 9, 2010
December 1, 2010
5.5 years
December 6, 2010
December 8, 2010
Conditions
Outcome Measures
Primary Outcomes (1)
Cardiac events defined as a composite of death, resuscitated cardiac arrest, spontaneous acute myocardial infarction and hospitalisation for congestive heart failure or unstable angina.
24 months
Secondary Outcomes (6)
Presence of unrecognized myocardial infarction
Baseline
Size and localisation of unrecognized myocardial infarction
Baseline
Degree and localization of artherosclerotic lesions at a coronary angiogram
Baseline
Procedure related acute myocardial infarction
5 years
Left ventricular mass and dimensions, levels of troponin and other biochemical markers, electrocardiography (ECG), anthropometric data
Baseline
- +1 more secondary outcomes
Eligibility Criteria
Patients with stable coronary artery disease without previously known myocardial infarction or coronary intervention
You may qualify if:
- symptoms of stable angina pectoris according to the treating physician
- scheduled for coronary angiography
- written informed consent
You may not qualify if:
- pathological Q-wave in the 12-lead resting ECG
- known previous myocardial infarction
- previous PCI (percutaneous coronary intervention) or CABG (coronary artery bypass graft)
- history of congestive heart failure
- anything that contraindicates a MRI investigation (e.g. pacemaker, claustrophobia, intracranial clips)
- lack of suitability for participation in the trial, for any reason, as judged by the Investigator.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
Falu Hospital
Falun, SE - 791 82, Sweden
Gävle Hospital
Gävle, SE - 801 82, Sweden
Linköping University Hospital
Linköping, SE - 581 85, Sweden
Örebro University Hospital
Örebro, SE-701 85, Sweden
Danderyds Hospital
Stockholm, SE - 182 88, Sweden
Uppsala University Hospital
Uppsala, SE-751 85, Sweden
Related Publications (3)
Nordenskjold AM, Hammar P, Ahlstrom H, Bjerner T, Duvernoy O, Eggers KM, Frobert O, Hadziosmanovic N, Lindahl B. Unrecognized Myocardial Infarction Assessed by Cardiac Magnetic Resonance Imaging--Prognostic Implications. PLoS One. 2016 Feb 17;11(2):e0148803. doi: 10.1371/journal.pone.0148803. eCollection 2016.
PMID: 26885831DERIVEDNordenskjold AM, Hammar P, Ahlstrom H, Bjerner T, Duvernoy O, Eggers KM, Frobert O, Hadziosmanovic N, Lindahl B. Unrecognized myocardial infarctions detected by cardiac magnetic resonance imaging are associated with cardiac troponin I levels. Clin Chim Acta. 2016 Apr 1;455:189-94. doi: 10.1016/j.cca.2016.01.029. Epub 2016 Jan 29.
PMID: 26828531DERIVEDHammar P, Nordenskjold AM, Lindahl B, Duvernoy O, Ahlstrom H, Johansson L, Hadziosmanovic N, Bjerner T. Unrecognized myocardial infarctions assessed by cardiovascular magnetic resonance are associated with the severity of the stenosis in the supplying coronary artery. J Cardiovasc Magn Reson. 2015 Nov 19;17:98. doi: 10.1186/s12968-015-0202-5.
PMID: 26585508DERIVED
Biospecimen
Plasma samples for biochemical markers. Whole blood samples for extraction of DNA for genetic analysis.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bertil Lindahl, professor
Uppsala University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 6, 2010
First Posted
December 9, 2010
Study Start
September 1, 2007
Primary Completion
March 1, 2013
Study Completion
March 1, 2013
Last Updated
December 9, 2010
Record last verified: 2010-12